Related references
Note: Only part of the references are listed.RNF43 overexpression attenuates the Wnt/β-catenin signalling pathway to suppress tumour progression in cholangiocarcinoma
Norma Sainstika Pangestu et al.
ONCOLOGY LETTERS (2021)
Role of miRNAs in prostate cancer: Do we really know everything?
Giovanni Cochetti et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2020)
Targeting DNA Damage Response in Prostate and Breast Cancer
Antje M. Wengner et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Treatment of Advanced Prostate Cancer
Min Yuen Teo et al.
ANNUAL REVIEW OF MEDICINE, VOL 70 (2019)
TCF4 induces enzalutamide resistance via neuroendocrine differentiation in prostate cancer
Geun Taek Lee et al.
PLOS ONE (2019)
The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges
Chin-Yap Loh et al.
CELLS (2019)
A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer associated with clinical outcome (vol 38, pg 913, 2019)
Nataly Stylianou et al.
ONCOGENE (2019)
MicroRNA-29a is a key regulon that regulates BRD4 and mitigates liver fibrosis in mice by inhibiting hepatic stellate cell activation
Ying-Hsien Huang et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2019)
MicroRNA-194 regulates cell viability and apoptosis by targeting CDH2 in prostatic cancer
Song Gao et al.
ONCOTARGETS AND THERAPY (2018)
Multiplex Gene Expression Profiling of In Vivo Isolated Circulating Tumor Cells in High-Risk Prostate Cancer Patients
Athina Markou et al.
CLINICAL CHEMISTRY (2018)
N-cadherin promotes epithelial-mesenchymal transition and cancer stem cell-like traits via ErbB signaling in prostate cancer cells
Min Wang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
MicroRNA-124 Functions as a Tumor Suppressor by Regulating CDH2 and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer
Teng Ma et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer
Steven Kregel et al.
ONCOTARGET (2016)
Curcumin inhibits cancer-associated fibroblast-driven prostate cancer invasion through MAOA/mTOR/HIF-1α signaling
Yuefeng Du et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
LEF1 Targeting EMT in Prostate Cancer Invasion Is Regulated by miR-34a
Jiaqian Liang et al.
MOLECULAR CANCER RESEARCH (2015)
mTOR Regulate EMT Through RhoA and Rac1 Pathway in Prostate Cancer
XianGuo Chen et al.
MOLECULAR CARCINOGENESIS (2015)
EMT and tumor metastasis
Sarah Heerboth et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2015)
A novel anti-cancer effect of resveratrol: reversal of epithelial-mesenchymal transition in prostate cancer cells
Jianping Li et al.
MOLECULAR MEDICINE REPORTS (2014)
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy REPLY
Tomasz M. Beer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Targeting of Alpha-V Integrins Reduces Malignancy of Bladder Carcinoma
Geertje van der Horst et al.
PLOS ONE (2014)
Role of the epithelial-mesenchymal transition and its effects on embryonic stem cells
Ye-Seul Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2014)
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
T. M. Beer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Epithelial-mesenchymal plasticity in carcinoma metastasis
Jeff H. Tsai et al.
GENES & DEVELOPMENT (2013)
Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance
L. Chang et al.
CELL DEATH & DISEASE (2013)
Snail mediates invasion through uPA/uPAR and the MAPK signaling pathway in prostate cancer cells
Diandra D. Randle et al.
ONCOLOGY LETTERS (2013)
Contemporary Role of Androgen Deprivation Therapy for Prostate Cancer
Vincenzo Pagliarulo et al.
EUROPEAN UROLOGY (2012)
Prolonged androgen deprivation leads to downregulation of androgen receptor and prostate-specific membrane antigen in prostate cancer cells
Tiancheng Liu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
N-cadherin mediates angiogenesis by regulating monocyte chemoattractant protein-1 expression via PI3K/Akt signaling in prostate cancer cells
Arun Kumar Nalla et al.
EXPERIMENTAL CELL RESEARCH (2011)
SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis
Berna Uygur et al.
MOLECULAR CANCER (2011)
N-cadherin increases after androgen deprivation and is associated with metastasis in prostate cancer
Karin Jennbacken et al.
ENDOCRINE-RELATED CANCER (2010)
Cancer-associated fibroblasts and epithelial-mesenchymal transition in metastatic oral tongue squamous cell carcinoma
Marilena Vered et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance
Hiroshi Tanaka et al.
NATURE MEDICINE (2010)
Slug/SNAI2 regulates cell proliferation and invasiveness of metastatic prostate cancer cell lines
Modjtaba Emadi Baygi et al.
TUMOR BIOLOGY (2010)
Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer
Farhad Vesuna et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
High-risk prostate cancer in the United States, 1990-2007
Matthew R. Cooperberg et al.
WORLD JOURNAL OF UROLOGY (2008)
Role of Wnt/β-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1α
Yong-Guang Jiang et al.
INTERNATIONAL JOURNAL OF UROLOGY (2007)
N-cadherin as a therapeutic target in cancer
Agnese Mariotti et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
Prostate cancer progression into androgen independency is associated with alterations in cell adhesion and invasivity
Karin Jennbacken et al.
PROSTATE (2006)
N-cadherin switching occurs in high Gleason grade prostate cancer
M Jaggi et al.
PROSTATE (2006)
N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling
LDM Derycke et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2004)
Share Paper
